Calton & Associates’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-21,060
| Closed | -$67.6K | – | 193 |
|
|
2023
Q4 | $67.6K | Buy |
+21,060
| New | +$67.6K | 0.03% | 241 |
|
|
2023
Q3 | – | Sell |
-22,907
| Closed | -$114K | – | 110 |
|
|
2023
Q2 | $114K | Sell |
22,907
-854
| -4% | -$4.24K | 0.05% | 203 |
|
|
2023
Q1 | $117K | Buy |
23,761
+7,447
| +46% | +$36.8K | 0.05% | 226 |
|
|
2022
Q4 | $103K | Buy |
16,314
+4,846
| +42% | +$30.5K | 0.04% | 272 |
|
|
2022
Q3 | $123K | Sell |
11,468
-5,884
| -34% | -$63.1K | 0.07% | 200 |
|
|
2022
Q2 | $197K | Sell |
17,352
-977
| -5% | -$11.1K | 0.11% | 220 |
|
|
2022
Q1 | $166K | Buy |
+18,329
| New | +$166K | 0.05% | 333 |
|
|
2021
Q4 | – | Sell |
-9,546
| Closed | -$245K | – | 368 |
|
|
2021
Q3 | $245K | Buy |
+9,546
| New | +$245K | 0.05% | 332 |
|
|
2021
Q2 | – | Sell |
-6,067
| Closed | -$214K | – | 408 |
|
|
2021
Q1 | $214K | Buy |
+6,067
| New | +$214K | 0.04% | 361 |
|